Drug Shortage Report for TEVA-IRBESARTAN HCTZ
Report ID | 209122 |
Drug Identification Number | 02330539 |
Brand name | TEVA-IRBESARTAN HCTZ |
Common or Proper name | TEVA-IRBESARTAN/HCTZ 300/25MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN HYDROCHLOROTHIAZIDE |
Strength(s) | 300MG 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-01 |
Estimated end date | 2024-03-10 |
Actual end date | 2024-03-06 |
Shortage status | Resolved |
Updated date | 2024-03-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2024-03-07 | French | Compare |
v16 | 2024-03-07 | English | Compare |
v15 | 2024-02-29 | French | Compare |
v14 | 2024-02-29 | English | Compare |
v13 | 2024-02-15 | French | Compare |
v12 | 2024-02-15 | English | Compare |
v11 | 2024-02-01 | French | Compare |
v10 | 2024-02-01 | English | Compare |
v9 | 2024-01-18 | French | Compare |
v8 | 2024-01-18 | English | Compare |
v7 | 2024-01-11 | French | Compare |
v6 | 2024-01-11 | English | Compare |
v5 | 2023-11-16 | French | Compare |
v4 | 2023-11-16 | English | Compare |
v3 | 2023-11-16 | English | Compare |
v2 | 2023-11-03 | French | Compare |
v1 | 2023-11-03 | English | Compare |
Showing 1 to 17 of 17